Aurovela 24 Fe Kit
Product Images NDC 65862-934

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aurovela 24 Fe (NDC 65862-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Norethindroneethinyl Fig1)

A forest plot comparing effect estimates of various studies on combined oral contraceptive (COC) use, divided into 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use.' The plot shows odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals for each study, with effect estimates plotted along the horizontal axis.*

FDA Label Image

Figure-2 (Norethindroneethinyl Fig2)

A line graph showing norethindrone concentration (pg/mL) over time (hours) on Day 1 and Day 24. The graph plots concentration with solid and dotted lines, indicating a peak shortly after administration followed by a decline, with higher concentrations observed on Day 24 compared to Day 1.*

FDA Label Image

Figure (Norethindroneethinyl Fig3)

A pharmacokinetic graph showing Ethinyl Estradiol concentration (pg/mL) over time (hours) comparing Day 1 and Day 24. Day 1 data are plotted with a solid line and filled circles, while Day 24 data use a dotted line and open circles, illustrating concentration changes up to 60 hours post-dose.*

FDA Label Image

Figure A (Norethindroneethinyl Fig4)

A vertical arrow chart illustrating the relative pregnancy rates per 100 women per year for various birth control methods. It ranges from fewer than 1 pregnancy to 85 or more pregnancies, categorizing methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Label)

Illustration of the Aurovela 24 Fe tablet calendar pack showing a 4-week pill schedule arranged by day of week from Sunday to Saturday. Circle markers indicate daily pill intake, with the last four pills in the fourth week shaded differently. Instructions advise to start on Sunday or the first day of the period and take pills from left to right each week.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Carton Label)

Aurovela 24 Fe kit label showing the active ingredients norethindrone acetate 1 mg and ethinyl estradiol 20 mcg, along with ferrous fumarate. The label indicates 28 day regimen packaging with 24 light yellow tablets and 4 brown tablets per pouch. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes NDC 65862-934-87 and states prescription only.*

FDA Label Image

Norethindroneethinyl Fig7

Aurovela 24 Fe kit packaging label for tablets containing Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate. The label highlights a 28-day regimen with 24 days of active therapy, dosage strength of 1 mg/20 mcg, and indicates it is manufactured by Aurobindo Pharma USA, Inc. The carton contains 5 pouches, each with a blister card of 28 tablets. The label includes storage instructions and warnings.*

FDA Label Image

Structure-1 (Norethindroneethinyl Str1)

Chemical structure of the active ingredient Ethinyl Estradiol, depicted with its characteristic four-ring steroid backbone, hydroxyl groups, and an alkyne side chain.*

FDA Label Image

Structure-2 (Norethindroneethinyl Str2)

Chemical structure of norethindrone acetate, an active ingredient in Aurovela 24 Fe. The diagram shows the molecular configuration with labeled atoms and chemical bonds characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.